Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

32.53 -0.42 (-1.27%)
Streaming Delayed Price Updated: 3:21 PM EDT, May 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Why Twist Bioscience Stock Is Sinking Today
Investors didn't like the synthetic DNA maker's guidance. 
Via The Motley Fool
Ford, Atlassian, Amazon And Other Big Stocks Moving Lower On Friday
U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Earnings Outlook For Twist Bioscience
Via Benzinga
The Latest Analyst Ratings for Twist Bioscience
Via Benzinga
5 Analysts Have This to Say About Twist Bioscience
Via Benzinga
Twist Bioscience Corporation (NASDAQ: TWST) Investor Alert: Deadline in Lawsuit on February 10, 2023
San Diego, CA -- (SBWIRE) -- 01/31/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 10, 2023 in the lawsuit filed for certain investors of Twist Bioscience... 
Via SBWire
DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Twist Bioscience Corporation Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TWST FINAL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the Future
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
NASDAQ:TWST Shareholder Alert: Lawsuit Alleges Misleading Statements by Twist Bioscience
San Diego, CA -- (SBWIRE) -- 01/19/2023 -- An investor, who purchased shares of Twist Bioscience Corporation (NASDAQ:TWST), filed a lawsuit over alleged violations of Federal Securities Laws by Twist... 
Via SBWire
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twist, Sunlight, Gaia, and Tattooed Chef and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Twist Bioscience Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research Collaboration
From Twist Bioscience Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NewAge, Twist, Sunlight and Gaia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Silvergate, Iris, NewAge, and Twist and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience to Present at the 41st Annual J.P. Morgan Health Care Conference
From Twist Bioscience Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
TWIST ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Twist Bioscience Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Twist Bioscience Corporation (TWST) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Twist Bioscience Corporation
From Robbins LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.